Related Experiment Video
Updated: Aug 5, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Chemotherapy for advanced breast cancer: a current perspective
1Breast and Gynecologic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Systemic therapy for metastatic breast cancer involves sequential chemotherapy. New agents like taxanes and monoclonal antibodies offer improved options, focusing on quality of life and cost-effectiveness for advanced disease management.
Area of Science:
- Oncology
- Pharmacology
Background:
- Hormone-refractory breast cancer (HRBC) with distant metastases requires systemic treatment.
- Traditional management relies on sequential cytotoxic chemotherapy.
Purpose of the Study:
- To review current and emerging systemic therapies for metastatic HRBC.
- To discuss the role of novel agents and treatment strategies.
Main Methods:
- Review of current literature on systemic therapy for metastatic breast cancer.
- Discussion of emerging agents and treatment paradigms.
Main Results:
- Taxanes represent a valuable alternative in HRBC treatment.
- Monoclonal antibodies targeting growth factor pathways show promise.
- Novel cytotoxic agents are under development for stage IV breast cancer.
Conclusions:
- New systemic agents offer improved therapeutic options for metastatic breast cancer.
- Future strategies should integrate quality of life and cost-effectiveness.
- Targeting growth factor pathways may provide a better therapeutic index.
More Related Videos
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
10:01Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...